Electrome

AI-Native Bioelectric Therapeutics Platform translating decades of bioelectric science into first-in-class treatments and novel combination therapies across high-burden disease areas — starting with Musculoskeletal Pain.

>Exclusive rights to only 510(k) cleared biolectric medical device (OTC+Rx) with broad claims across pain, inflammation, and post surgical recovery >Actively selling into the VA at ~87% margin >Pain management platform live at www.painkiller.care >Reimbursement pathway through CMS 'No Pain' opioid-reduction program >LOIs from 3,700 independent pharmacies >2 licensed, 8 provisional and 2 utility patents pending